aTyr Pharma Inc (LIFE)
1.62
-0.02
(-1.22%)
USD |
NASDAQ |
Apr 23, 16:00
1.62
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.353M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 10.39M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 |
| Date | Value |
|---|---|
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 2.053M |
| September 30, 2020 | 0.148M |
| June 30, 2020 | 0.189M |
| March 31, 2020 | 8.065M |
| December 31, 2019 | 0.144M |
| September 30, 2019 | 0.184M |
| June 30, 2019 | 0.094M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.094M
Minimum
Jun 2019
10.39M
Maximum
Dec 2022
2.402M
Average
0.189M
Median
Jun 2020
Revenue (Quarterly) Benchmarks
| Vaxart Inc | 6.625M |
| Allogene Therapeutics Inc | -0.044M |
| AIM ImmunoTech Inc | 0.065M |
| Protalix BioTherapeutics Inc | 10.49M |
| Armata Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.76M |
| Total Expenses (Quarterly) | 15.96M |
| EPS Diluted (Quarterly) | -0.25 |
| Enterprise Value | 12.76M |
| Earnings Yield | -59.26% |
| Normalized Earnings Yield | -59.88 |